Esperion Therapeutics Inc.. (ESPR) NASDAQ

$1.95 0.08 (4.28%)

Market Cap: $369.33M

As of 04/19/24 04:00 PM EDT. Market closed.

(ESPR)

Esperion Therapeutics Inc.. (ESPR)
NASDAQ

$1.95
0.08 (4.28%)

Market Cap: $369.33M

As of 04/19/24 04:00 PM EDT. Market closed.

Add to Portfolio

esperion therapeutics, inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, ldl-c lowering therapies for the treatment of patients with hypercholesterolemia. etc-1002, the company's lead product candidate, is an inhibitor of atp citrate lyase, a well-characterized enzyme on the cholesterol biosynthesis pathway; the same pathway that includes hmg-coa ... read more

esperion therapeutics, inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, ldl-c lowering therapies for the treatment of patients with hypercholesterolemia. etc-1002, the company's lead product candidate, is an inhibitor of atp citrate lyase, a well-characterized enzyme on the cholesterol biosynthesis pathway; the same pathway that includes hmg-coa reductase, the enzyme target of statins. the company has successfully completed its phase 1 and phase 2 development programs for etc-1002, and plans to initiate its etc-1002 phase 3 development program by the end of 2015. for more information, please visit www.esperion.com. read less

COMPANY PROFILE
Sector
Industry
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.72M
URL
Address
3891 Ranchero Dr Ste 150, Michigan, Ann Arbor, 48108-2837.
Sector
Industry
CEO
Timothy Mayleben
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.72M
Address
3891 Ranchero Dr Ste 150, Michigan, Ann Arbor, 48108-2837.
PRICE CHART FOR ESPERION THERAPEUTICS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.82
Previous Close
$1.87
Days Range
$1.72 - $1.97
52 week range
$0.70 - $3.40
Volume
7,350,406
Avg. Volume (30 days)
8,970,220
Market Cap
$369.33M
Dividend Yield
-
P/E
(1.77)
Shares Outstanding
189,400,567
Open
$1.82
Previous Close
$1.87
Days Range
$1.72 - $1.97
52 week range
$0.70 - $3.40
Volume
7,350,406
Avg. Volume (30 days)
8,970,220
Market Cap
$369.33M
Dividend Yield
-
P/E
(1.77)
Shares Outstanding
189,400,567
FINANCIAL STATEMENTS FOR ESPERION THERAPEUTICS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ESPERION THERAPEUTICS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Warren EricChief Commercial OfficerSep 20, 2023 Sale$1.2574292468,318Sep 21, 2023, 05:06 PM
Warren EricChief Commercial OfficerAug 18, 2023 Sale$1.4124334469,060Aug 21, 2023, 04:32 PM
Warren EricChief Commercial OfficerJul 19, 2023 Sale$1.5910616869,303Jul 20, 2023, 04:38 PM
Warren EricChief Commercial OfficerJun 21, 2023 Sale$1.4860389469,409Jun 22, 2023, 04:45 PM
Warren EricChief Commercial OfficerMay 17, 2023 Sale$1.6221935670,012May 18, 2023, 04:07 PM
CARROLL J MARTINDirectorMay 11, 2023 Buy$1.5723,09136,28536,500May 11, 2023, 04:11 PM
CARROLL J MARTINDirectorMay 10, 2023 Buy$1.498,40912,54513,409May 11, 2023, 04:11 PM
ROCAMBOLI STEPHENDirectorMay 10, 2023 Buy$1.508,11112,1268,111May 11, 2023, 04:10 PM
Koenig Sheldon L.President and CEOMay 09, 2023 Buy$1.2620,00025,192312,816May 10, 2023, 04:12 PM
Warren EricChief Commercial OfficerApr 19, 2023 Sale$1.2811514770,231Apr 20, 2023, 04:12 PM
Looker BenjaminGeneral CounselApr 19, 2023 Sale$1.271,2901,64183,663Apr 20, 2023, 04:12 PM
Foody Joanne M.Chief Medical OfficerApr 19, 2023 Sale$1.279381,192127,064Apr 20, 2023, 04:11 PM
Foody Joanne M.Chief Medical OfficerMar 17, 2023 Sale$1.783,8086,785128,002Mar 20, 2023, 04:19 PM
Koenig Sheldon L.President and CEOMar 17, 2023 Sale$1.786,99912,479292,816Mar 20, 2023, 04:16 PM
Warren EricChief Commercial OfficerMar 17, 2023 Sale$1.7852693770,346Mar 20, 2023, 04:16 PM
Warren EricChief Commercial OfficerMar 07, 2023 Sale$5.055,09025,73048,572Mar 08, 2023, 04:22 PM
Koenig Sheldon L.President and CEOMar 07, 2023 Sale$5.065,44127,510194,815Mar 08, 2023, 04:21 PM
Foody Joanne M.Chief Medical OfficerMar 07, 2023 Sale$5.073,88419,672103,060Mar 08, 2023, 04:20 PM
Looker BenjaminGeneral CounselJan 18, 2023 Sale$7.006,34744,40464,453Jan 19, 2023, 04:58 PM
Foody Joanne M.Chief Medical OfficerJan 18, 2023 Sale$6.991,1918,319106,944Jan 19, 2023, 04:58 PM
Foody Joanne M.Chief Medical OfficerOct 18, 2022 Sale$7.699427,242108,135Oct 19, 2022, 04:13 PM
Warren EricChief Commercial OfficerOct 18, 2022 Sale$7.6910782353,662Oct 19, 2022, 04:11 PM
Warren EricChief Commercial OfficerSep 19, 2022 Sale$6.922551,76553,769Sep 20, 2022, 04:09 PM
Koenig Sheldon L.President and CEOSep 19, 2022 Sale$6.943,39423,548198,257Sep 20, 2022, 04:08 PM
Warren EricChief Commercial OfficerAug 31, 2022 Buy$7.461,0007,46054,024Aug 31, 2022, 04:14 PM
Warren EricChief Commercial OfficerAug 17, 2022 Sale$6.821991,35653,024Aug 18, 2022, 04:10 PM
Koenig Sheldon L.President and CEOAug 05, 2022 Buy$5.808,60649,950198,771Aug 08, 2022, 04:14 PM
Foody Joanne M.Chief Medical OfficerJul 19, 2022 Sale$6.553,90125,552109,077Jul 20, 2022, 04:27 PM
Warren EricChief Commercial OfficerJul 19, 2022 Sale$6.584312,83753,223Jul 20, 2022, 04:27 PM
Koenig Sheldon L.President and CEOJun 17, 2022 Sale$4.994,55222,719190,165Jun 21, 2022, 04:07 PM
Warren EricChief Commercial OfficerJun 17, 2022 Sale$4.902561,25453,654Jun 21, 2022, 04:06 PM
CARROLL J MARTINDirectorJun 02, 2022 Buy$5.645,00028,1805,000Jun 03, 2022, 04:11 PM
Warren EricChief Commercial OfficerMay 17, 2022 Sale$5.981961,17253,910May 18, 2022, 04:30 PM
Koenig Sheldon L.President and CEOMar 17, 2022 Sale$4.585712,615194,717Mar 18, 2022, 04:29 PM
BIOTECH TARGET N V10% OwnerMay 24, 2021 Buy$20.22100,0002,021,6204,477,964May 26, 2021, 11:53 AM
BIOTECH TARGET N V10% OwnerMay 06, 2021 Buy$20.5780,0001,645,6324,177,964May 07, 2021, 03:23 PM
BIOTECH TARGET N V10% OwnerMay 05, 2021 Buy$20.02150,0003,002,8504,097,964May 07, 2021, 03:23 PM
MAYLEBEN TIMOTHY MPresident & CEODec 30, 2020 Option Exercise$2.1010,70022,427122,698Dec 31, 2020, 04:09 PM
BIOTECH TARGET N V10% OwnerNov 03, 2020 Buy$25.31200,0005,062,1203,947,964Nov 04, 2020, 04:37 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 11, 2020 Buy$43.002,500107,500111,998Mar 12, 2020, 07:34 AM
MAYLEBEN TIMOTHY MPresident & CEOFeb 28, 2020 Buy$49.005,000245,000109,498Mar 02, 2020, 06:16 AM
BIOTECH TARGET N V10% OwnerJan 23, 2020 Buy$52.1220,0001,042,3983,747,964Jan 27, 2020, 12:51 PM
MAYLEBEN TIMOTHY MPresident & CEONov 06, 2019 Buy$36.985,000184,90083,663Nov 08, 2019, 04:14 PM
BIOTECH TARGET N V10% OwnerNov 06, 2019 Buy$37.3075,0002,797,5603,727,964Nov 08, 2019, 02:54 PM
MAYLEBEN TIMOTHY MPresident & CEOSep 06, 2019 Buy$35.252,50088,12578,663Sep 06, 2019, 04:22 PM
MAYLEBEN TIMOTHY MPresident & CEOSep 04, 2019 Buy$34.205,000170,98276,163Sep 06, 2019, 04:22 PM
BIOTECH TARGET N V10% OwnerSep 04, 2019 Buy$33.7880,0002,702,2083,652,964Sep 06, 2019, 04:09 PM
MAYLEBEN TIMOTHY MPresident & CEOAug 01, 2019 Buy$39.565,000197,80071,163Aug 02, 2019, 04:06 PM
BIOTECH TARGET N V10% OwnerJul 23, 2019 Buy$42.6550,0002,132,5653,572,964Jul 25, 2019, 12:42 PM
MAYLEBEN TIMOTHY MPresident & CEOJun 28, 2019 Buy$46.005,000230,00066,163Jul 01, 2019, 04:57 PM
Bartram RichardChief Financial OfficerApr 03, 2019 Sale$42.888,000343,04512,592Apr 05, 2019, 05:23 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 29, 2019 Buy$40.005,000200,00061,163Apr 01, 2019, 04:41 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 20, 2019 Buy$43.485,000217,40056,163Mar 21, 2019, 05:01 PM
VITULLO NICOLEDirectorMar 19, 2019 Sale$44.7315,329685,5961,700Mar 21, 2019, 09:02 AM
BIOTECH TARGET N V10% OwnerMar 14, 2019 Buy$49.8950,0002,494,3553,522,964Mar 15, 2019, 07:50 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 14, 2019 Buy$48.735,000243,65051,163Mar 14, 2019, 04:57 PM
NEWTON ROGER SDirectorMar 12, 2019 Sale$50.0625,0001,251,500548,726Mar 14, 2019, 04:57 PM
BIOTECH TARGET N V10% OwnerJan 04, 2019 Buy$41.2980,0003,303,2563,472,964Jan 07, 2019, 05:10 PM
BIOTECH TARGET N V10% OwnerDec 24, 2018 Buy$39.9150,0001,995,7253,392,964Dec 26, 2018, 11:44 AM
BIOTECH TARGET N V10% OwnerDec 17, 2018 Buy$47.7360,0002,864,0703,342,964Dec 19, 2018, 01:14 PM
Boxer Capital, LLC10% OwnerNov 05, 2018 Sale$57.1660,0003,429,8431,134,750Nov 05, 2018, 07:56 PM
Boxer Capital, LLC10% OwnerNov 02, 2018 Sale$55.2140,0002,208,5001,198,750Nov 05, 2018, 07:56 PM
NEWTON ROGER SDirectorNov 02, 2018 Sale$50.7622711,523573,726Nov 02, 2018, 05:00 PM
NEWTON ROGER SDirectorNov 01, 2018 Sale$50.012,600130,026573,953Nov 02, 2018, 05:00 PM
NEWTON ROGER SDirectorOct 16, 2018 Sale$50.019,400470,094589,326Oct 18, 2018, 05:05 PM
NEWTON ROGER SDirectorOct 18, 2018 Sale$50.001005,000576,553Oct 18, 2018, 05:05 PM
NEWTON ROGER SDirectorOct 17, 2018 Sale$50.0212,673633,903576,653Oct 18, 2018, 05:05 PM
NEWTON ROGER SDirectorAug 27, 2018 Sale$51.0517,700903,610615,726Aug 29, 2018, 04:56 PM
NEWTON ROGER SDirectorAug 17, 2018 Sale$50.067,300365,438616,426Aug 22, 2018, 07:18 AM
BIOTECH TARGET N V10% OwnerAug 03, 2018 Buy$46.1450,0002,306,9703,282,964Aug 06, 2018, 03:23 PM
BIOTECH TARGET N V10% OwnerJul 12, 2018 Buy$41.7750,0002,088,3003,232,964Jul 13, 2018, 11:45 AM
BIOTECH TARGET N V10% OwnerJun 29, 2018 Buy$39.4850,0001,973,8053,182,964Jul 03, 2018, 11:55 AM
BIOTECH TARGET N V10% OwnerJun 21, 2018 Buy$38.5760,0002,314,2243,132,964Jun 25, 2018, 12:43 PM
BIOTECH TARGET N V10% OwnerJun 07, 2018 Buy$37.7960,0002,267,2923,072,964Jun 11, 2018, 02:59 PM
GOLDSTEIN DOV A MDDirectorJun 06, 2018 Option Exercise$16.4713,000214,10013,047Jun 08, 2018, 05:08 PM
BIOTECH TARGET N V10% OwnerJun 05, 2018 Buy$38.4760,0002,308,4403,012,964Jun 07, 2018, 02:34 PM
BIOTECH TARGET N V10% OwnerMay 21, 2018 Buy$38.7780,0003,101,7602,952,964May 22, 2018, 03:49 PM
BIOTECH TARGET N V10% OwnerMay 18, 2018 Buy$42.2450,0002,112,0102,872,964May 22, 2018, 03:49 PM
NEWTON ROGER SDirectorMar 29, 2018 Sale$72.3725,0001,809,277639,682Mar 29, 2018, 07:47 PM
NEWTON ROGER SDirectorFeb 07, 2018 Option Exercise$6.993,60825,220648,726Feb 09, 2018, 05:47 PM
NEWTON ROGER SDirectorFeb 07, 2018 Option Exercise$6.9934,651242,210652,334Feb 09, 2018, 05:47 PM
MAYLEBEN TIMOTHY MPresident & CEOJan 31, 2018 Option Exercise$1.174,5495,32546,163Feb 01, 2018, 05:29 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$71.826,814489,3811,101,080Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$71.821178,40327,003Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$6.9970,042489,5941,107,894Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$6.991,1938,33927,120Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 25, 2018 Sale$71.7911,674838,07615,329Jan 26, 2018, 05:24 PM
JANNEY DANIELDirectorJan 18, 2018 Option Exercise$74.966,640497,734624,564Jan 22, 2018, 08:49 PM
JANNEY DANIELDirectorJan 18, 2018 Option Exercise$6.9971,237497,947631,204Jan 22, 2018, 08:49 PM
Bartram RichardChief Financial OfficerJan 02, 2018 Option Exercise$3.7017,89266,20019,092Jan 03, 2018, 06:01 PM
GOLDSTEIN DOV A MDDirectorDec 18, 2017 Option Exercise$3.7021,47179,44321,518Dec 20, 2017, 05:53 PM
VITULLO NICOLEDirectorDec 06, 2017 Sale$53.859,326502,20525,927Dec 08, 2017, 04:14 PM
JANNEY DANIELDirectorMar 21, 2017 Sale$45.80350,00016,029,2631,588,627Mar 23, 2017, 04:45 PM
GOLDSTEIN DOV A MDDirectorMar 21, 2017 Sale$43.48487,35821,190,3261,149,767Mar 23, 2017, 04:37 PM
GOLDSTEIN DOV A MDDirectorMar 22, 2017 Sale$38.82312,64212,136,762837,125Mar 23, 2017, 04:37 PM
OMENN GILBERT SDirectorMar 21, 2017 Buy$42.261,00042,2601,000Mar 22, 2017, 08:02 AM
Lalwani Narendra D.Chief Operating OfficerNov 01, 2016 Buy$9.935,00049,6505,000Nov 03, 2016, 05:58 PM
MCGOVERN MARK EDirectorJul 06, 2016 Buy$10.004,40044,0005,000Jul 07, 2016, 07:17 AM
MCGOVERN MARK EDirectorJul 05, 2016 Buy$10.006006,000600Jul 07, 2016, 07:17 AM
MAYLEBEN TIMOTHY MPresident & CEOMay 04, 2016 Buy$14.857,000103,95041,614May 05, 2016, 07:33 AM
OMENN GILBERT SDirectorMar 01, 2016 Buy$15.285,00076,40010,000Mar 02, 2016, 07:23 AM
MAYLEBEN TIMOTHY MPresident & CEOJan 27, 2016 Buy$15.883,60057,16834,614Jan 28, 2016, 06:22 PM
MAYLEBEN TIMOTHY MPresident & CEOJan 15, 2016 Buy$14.087,200101,37631,014Jan 19, 2016, 07:16 AM
Aisling Capital II LP10% OwnerApr 24, 2015 Sale$106.2667,4697,169,3731,898,851Apr 27, 2015, 06:33 PM
Aisling Capital II LP10% OwnerApr 23, 2015 Sale$109.10150,00016,365,0001,904,594Apr 27, 2015, 06:33 PM
GOLDSTEIN DOV A MDDirectorApr 24, 2015 Sale$106.2667,4697,169,3731,898,851Apr 27, 2015, 06:32 PM
GOLDSTEIN DOV A MDDirectorApr 23, 2015 Sale$109.10150,00016,365,0001,904,594Apr 27, 2015, 06:32 PM
ENRIGHT PATRICK GDirectorMar 19, 2015 Sale$111.669,8251,097,09922,502Mar 23, 2015, 04:06 PM
ENRIGHT PATRICK GDirectorMar 19, 2015 Sale$111.66490,17554,734,4711,122,609Mar 23, 2015, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 18, 2014 Sale$31.611003,16128,194Nov 19, 2014, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 18, 2014 Sale$31.615,004158,1841,406,622Nov 19, 2014, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 17, 2014 Sale$32.799,471310,53733,736Nov 19, 2014, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 17, 2014 Sale$32.79472,55515,494,2851,683,178Nov 19, 2014, 04:06 PM
ENRIGHT PATRICK GDirectorNov 17, 2014 Sale$32.799,471310,53733,736Nov 19, 2014, 04:05 PM
ENRIGHT PATRICK GDirectorNov 17, 2014 Sale$32.79472,55515,494,2851,683,178Nov 19, 2014, 04:05 PM
ENRIGHT PATRICK GDirectorNov 18, 2014 Sale$31.611003,16128,194Nov 19, 2014, 04:05 PM
ENRIGHT PATRICK GDirectorNov 18, 2014 Sale$31.615,004158,1841,406,622Nov 19, 2014, 04:05 PM
Alta Partners VIII, L.P.10% OwnerOct 21, 2014 Buy$20.00500,00010,000,0002,552,189Oct 21, 2014, 07:33 PM
JANNEY DANIELDirectorOct 21, 2014 Buy$20.00500,00010,000,0002,552,189Oct 21, 2014, 06:53 PM
OMENN GILBERT SDirectorOct 21, 2014 Buy$20.005,000100,0005,000Oct 21, 2014, 05:31 PM
DOMAIN PARTERS VII L P10% OwnerOct 21, 2014 Buy$20.00500,00010,000,0002,566,935Oct 21, 2014, 12:15 PM
Longitude Capital Partners, LLC10% OwnerOct 09, 2014 Sale$30.001957037,757Oct 14, 2014, 06:54 AM
Longitude Capital Partners, LLC10% OwnerOct 09, 2014 Sale$30.0092427,7201,883,769Oct 14, 2014, 06:54 AM
ENRIGHT PATRICK GDirectorOct 09, 2014 Sale$30.001957037,757Oct 14, 2014, 06:51 AM
ENRIGHT PATRICK GDirectorOct 09, 2014 Sale$30.0092427,7201,883,769Oct 14, 2014, 06:51 AM
ENRIGHT PATRICK GDirectorOct 07, 2014 Sale$30.042357,05937,776Oct 09, 2014, 04:03 PM
ENRIGHT PATRICK GDirectorOct 07, 2014 Sale$30.0411,692351,2301,884,693Oct 09, 2014, 04:03 PM
Longitude Capital Partners, LLC10% OwnerOct 07, 2014 Sale$30.0411,692351,2301,884,693Oct 09, 2014, 04:02 PM
Longitude Capital Partners, LLC10% OwnerOct 07, 2014 Sale$30.042357,05937,776Oct 09, 2014, 04:02 PM
BLAIR JAMES C10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 05:03 PM
BLAIR JAMES C10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 05:03 PM
DP VII ASSOCIATES LP10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 05:00 PM
DOMAIN PARTERS VII L P10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:55 PM
Halak Brian K10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:51 PM
Halak Brian K10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:51 PM
DOVEY BRIAN H10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:48 PM
DOVEY BRIAN H10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:48 PM
SCHOEMAKER KATHLEEN K10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:40 PM
SCHOEMAKER KATHLEEN K10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:40 PM
TREU JESSE I10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:35 PM
TREU JESSE I10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:35 PM
VITULLO NICOLEDirectorJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:31 PM
VITULLO NICOLEDirectorJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:31 PM
Longitude Capital Partners, LLC10% OwnerJul 01, 2013 Buy$14.00212,4182,973,8521,896,385Jul 01, 2013, 04:40 PM
Longitude Capital Partners, LLC10% OwnerJul 01, 2013 Buy$14.004,25859,61238,011Jul 01, 2013, 04:40 PM
MAYLEBEN TIMOTHY MPresident and CEOJul 01, 2013 Buy$14.005,00070,00028,814Jul 01, 2013, 04:39 PM
NEWTON ROGER SExecutive Chairman, CSOJul 01, 2013 Buy$14.0042,346592,844629,683Jul 01, 2013, 04:38 PM
LANGE LOUIS GDirectorJul 01, 2013 Buy$14.0010,714149,996197,703Jul 01, 2013, 04:38 PM
LANGE LOUIS GDirectorJul 01, 2013 Buy$14.003,50049,00017,814Jul 01, 2013, 04:38 PM
GOLDSTEIN DOV A MDDirectorJul 01, 2013 Buy$14.00238,1193,333,6662,054,594Jul 01, 2013, 04:37 PM
ENRIGHT PATRICK GDirectorJul 01, 2013 Buy$14.004,25859,61238,011Jul 01, 2013, 04:36 PM
ENRIGHT PATRICK GDirectorJul 01, 2013 Buy$14.00212,4182,973,8521,896,385Jul 01, 2013, 04:36 PM
JANNEY DANIELDirectorJul 01, 2013 Buy$14.00235,7143,299,9962,052,189Jul 01, 2013, 04:34 PM
Alta Partners VIII, L.P.10% OwnerJul 01, 2013 Buy$14.00235,7143,299,9962,052,189Jul 01, 2013, 04:33 PM
Aisling Capital II LP10% OwnerJul 01, 2013 Buy$14.00238,1193,333,6662,054,594Jul 01, 2013, 04:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Warren EricChief Commercial Officer09/20/2023924
Warren EricChief Commercial Officer08/18/2023344
Warren EricChief Commercial Officer07/19/2023168
Warren EricChief Commercial Officer06/21/2023894
Warren EricChief Commercial Officer05/17/2023356
CARROLL J MARTINDirector05/11/202336,285
CARROLL J MARTINDirector05/10/202312,545
ROCAMBOLI STEPHENDirector05/10/202312,126
Koenig Sheldon L.President and CEO05/09/202325,192
Warren EricChief Commercial Officer04/19/2023147
Looker BenjaminGeneral Counsel04/19/20231,641
Foody Joanne M.Chief Medical Officer04/19/20231,192
Foody Joanne M.Chief Medical Officer03/17/20236,785
Koenig Sheldon L.President and CEO03/17/202312,479
Warren EricChief Commercial Officer03/17/2023937
Warren EricChief Commercial Officer03/07/202325,730
Koenig Sheldon L.President and CEO03/07/202327,510
Foody Joanne M.Chief Medical Officer03/07/202319,672
Looker BenjaminGeneral Counsel01/18/202344,404
Foody Joanne M.Chief Medical Officer01/18/20238,319
Foody Joanne M.Chief Medical Officer10/18/20227,242
Warren EricChief Commercial Officer10/18/2022823
Warren EricChief Commercial Officer09/19/20221,765
Koenig Sheldon L.President and CEO09/19/202223,548
Warren EricChief Commercial Officer08/31/20227,460
Warren EricChief Commercial Officer08/17/20221,356
Koenig Sheldon L.President and CEO08/05/202249,950
Foody Joanne M.Chief Medical Officer07/19/202225,552
Warren EricChief Commercial Officer07/19/20222,837
Koenig Sheldon L.President and CEO06/17/202222,719
Warren EricChief Commercial Officer06/17/20221,254
CARROLL J MARTINDirector06/02/202228,180
Warren EricChief Commercial Officer05/17/20221,172
Koenig Sheldon L.President and CEO03/17/20222,615
BIOTECH TARGET N V10% Owner05/24/20212,021,620
BIOTECH TARGET N V10% Owner05/06/20211,645,632
BIOTECH TARGET N V10% Owner05/05/20213,002,850
MAYLEBEN TIMOTHY MPresident & CEO12/30/202022,427
BIOTECH TARGET N V10% Owner11/03/20205,062,120
MAYLEBEN TIMOTHY MPresident & CEO03/11/2020107,500
MAYLEBEN TIMOTHY MPresident & CEO02/28/2020245,000
BIOTECH TARGET N V10% Owner01/23/20201,042,398
MAYLEBEN TIMOTHY MPresident & CEO11/06/2019184,900
BIOTECH TARGET N V10% Owner11/06/20192,797,560
MAYLEBEN TIMOTHY MPresident & CEO09/06/201988,125
MAYLEBEN TIMOTHY MPresident & CEO09/04/2019170,982
BIOTECH TARGET N V10% Owner09/04/20192,702,208
MAYLEBEN TIMOTHY MPresident & CEO08/01/2019197,800
BIOTECH TARGET N V10% Owner07/23/20192,132,565
MAYLEBEN TIMOTHY MPresident & CEO06/28/2019230,000
Bartram RichardChief Financial Officer04/03/2019343,045
MAYLEBEN TIMOTHY MPresident & CEO03/29/2019200,000
MAYLEBEN TIMOTHY MPresident & CEO03/20/2019217,400
VITULLO NICOLEDirector03/19/2019685,596
BIOTECH TARGET N V10% Owner03/14/20192,494,355
MAYLEBEN TIMOTHY MPresident & CEO03/14/2019243,650
NEWTON ROGER SDirector03/12/20191,251,500
BIOTECH TARGET N V10% Owner01/04/20193,303,256
BIOTECH TARGET N V10% Owner12/24/20181,995,725
BIOTECH TARGET N V10% Owner12/17/20182,864,070
Boxer Capital, LLC10% Owner11/05/20183,429,843
Boxer Capital, LLC10% Owner11/02/20182,208,500
NEWTON ROGER SDirector11/02/201811,523
NEWTON ROGER SDirector11/01/2018130,026
NEWTON ROGER SDirector10/16/2018470,094
NEWTON ROGER SDirector10/18/20185,000
NEWTON ROGER SDirector10/17/2018633,903
NEWTON ROGER SDirector08/27/2018903,610
NEWTON ROGER SDirector08/17/2018365,438
BIOTECH TARGET N V10% Owner08/03/20182,306,970
BIOTECH TARGET N V10% Owner07/12/20182,088,300
BIOTECH TARGET N V10% Owner06/29/20181,973,805
BIOTECH TARGET N V10% Owner06/21/20182,314,224
BIOTECH TARGET N V10% Owner06/07/20182,267,292
GOLDSTEIN DOV A MDDirector06/06/2018214,100
BIOTECH TARGET N V10% Owner06/05/20182,308,440
BIOTECH TARGET N V10% Owner05/21/20183,101,760
BIOTECH TARGET N V10% Owner05/18/20182,112,010
NEWTON ROGER SDirector03/29/20181,809,277
NEWTON ROGER SDirector02/07/201825,220
NEWTON ROGER SDirector02/07/2018242,210
MAYLEBEN TIMOTHY MPresident & CEO01/31/20185,325
VITULLO NICOLEDirector01/24/2018489,381
VITULLO NICOLEDirector01/24/20188,403
VITULLO NICOLEDirector01/24/2018489,594
VITULLO NICOLEDirector01/24/20188,339
VITULLO NICOLEDirector01/25/2018838,076
JANNEY DANIELDirector01/18/2018497,734
JANNEY DANIELDirector01/18/2018497,947
Bartram RichardChief Financial Officer01/02/201866,200
GOLDSTEIN DOV A MDDirector12/18/201779,443
VITULLO NICOLEDirector12/06/2017502,205
JANNEY DANIELDirector03/21/201716,029,263
GOLDSTEIN DOV A MDDirector03/21/201721,190,326
GOLDSTEIN DOV A MDDirector03/22/201712,136,762
OMENN GILBERT SDirector03/21/201742,260
Lalwani Narendra D.Chief Operating Officer11/01/201649,650
MCGOVERN MARK EDirector07/06/201644,000
MCGOVERN MARK EDirector07/05/20166,000
MAYLEBEN TIMOTHY MPresident & CEO05/04/2016103,950
OMENN GILBERT SDirector03/01/201676,400
MAYLEBEN TIMOTHY MPresident & CEO01/27/201657,168
MAYLEBEN TIMOTHY MPresident & CEO01/15/2016101,376
Aisling Capital II LP10% Owner04/24/20157,169,373
Aisling Capital II LP10% Owner04/23/201516,365,000
GOLDSTEIN DOV A MDDirector04/24/20157,169,373
GOLDSTEIN DOV A MDDirector04/23/201516,365,000
ENRIGHT PATRICK GDirector03/19/20151,097,099
ENRIGHT PATRICK GDirector03/19/201554,734,471
Longitude Capital Partners, LLC10% Owner11/18/20143,161
Longitude Capital Partners, LLC10% Owner11/18/2014158,184
Longitude Capital Partners, LLC10% Owner11/17/2014310,537
Longitude Capital Partners, LLC10% Owner11/17/201415,494,285
ENRIGHT PATRICK GDirector11/17/2014310,537
ENRIGHT PATRICK GDirector11/17/201415,494,285
ENRIGHT PATRICK GDirector11/18/20143,161
ENRIGHT PATRICK GDirector11/18/2014158,184
Alta Partners VIII, L.P.10% Owner10/21/201410,000,000
JANNEY DANIELDirector10/21/201410,000,000
OMENN GILBERT SDirector10/21/2014100,000
DOMAIN PARTERS VII L P10% Owner10/21/201410,000,000
Longitude Capital Partners, LLC10% Owner10/09/2014570
Longitude Capital Partners, LLC10% Owner10/09/201427,720
ENRIGHT PATRICK GDirector10/09/2014570
ENRIGHT PATRICK GDirector10/09/201427,720
ENRIGHT PATRICK GDirector10/07/20147,059
ENRIGHT PATRICK GDirector10/07/2014351,230
Longitude Capital Partners, LLC10% Owner10/07/2014351,230
Longitude Capital Partners, LLC10% Owner10/07/20147,059
BLAIR JAMES C10% Owner07/01/201367,074
BLAIR JAMES C10% Owner07/01/20133,932,922
DP VII ASSOCIATES LP10% Owner07/01/201367,074
DOMAIN PARTERS VII L P10% Owner07/01/20133,932,922
Halak Brian K10% Owner07/01/201367,074
Halak Brian K10% Owner07/01/20133,932,922
DOVEY BRIAN H10% Owner07/01/201367,074
DOVEY BRIAN H10% Owner07/01/20133,932,922
SCHOEMAKER KATHLEEN K10% Owner07/01/201367,074
SCHOEMAKER KATHLEEN K10% Owner07/01/20133,932,922
TREU JESSE I10% Owner07/01/201367,074
TREU JESSE I10% Owner07/01/20133,932,922
VITULLO NICOLEDirector07/01/201367,074
VITULLO NICOLEDirector07/01/20133,932,922
Longitude Capital Partners, LLC10% Owner07/01/20132,973,852
Longitude Capital Partners, LLC10% Owner07/01/201359,612
MAYLEBEN TIMOTHY MPresident and CEO07/01/201370,000
NEWTON ROGER SExecutive Chairman, CSO07/01/2013592,844
LANGE LOUIS GDirector07/01/2013149,996
LANGE LOUIS GDirector07/01/201349,000
GOLDSTEIN DOV A MDDirector07/01/20133,333,666
ENRIGHT PATRICK GDirector07/01/201359,612
ENRIGHT PATRICK GDirector07/01/20132,973,852
JANNEY DANIELDirector07/01/20133,299,996
Alta Partners VIII, L.P.10% Owner07/01/20133,299,996
Aisling Capital II LP10% Owner07/01/20133,333,666
Load More Insider Transactions
FUNDS WITH A POSITION IN ESPERION THERAPEUTICS INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
PLATINUM INVESTMENT MANAGEMENT LTD2,810,5550.34%-11.88%Growth At A Reasonable Price, Value
BLACKROCK INC.2,112,8990.00016%7.37%Other
RENAISSANCE TECHNOLOGIES LLC1,420,1000.00657%588.85%Other
D. E. SHAW & CO., INC.1,213,2030.00317%NewOther
GEODE CAPITAL MANAGEMENT, LLC1,112,2460.00035%14.64%Other
UBS OCONNOR LLC527,1230.11%-16.59%Value
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP222,4820.02%No changeEvent Driven
BALYASNY ASSET MANAGEMENT L.P.37,1880.00021%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR ESPERION THERAPEUTICS INC.
STOCK BUYBACKS FOR ESPERION THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.57%
1Q
12/31/2023
06/30/2023
2.99%
2Q
12/31/2023
09/30/2022
65.92%
5Q
12/31/2023
06/30/2022
77.94%
6Q
12/31/2023
03/31/2022
84.57%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.57%
1Q
06/30/2023
2.99%
2Q
09/30/2022
65.92%
5Q
06/30/2022
77.94%
6Q
03/31/2022
84.57%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ESPERION THERAPEUTICS INC.
LOADING...